One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan

Abstract This multicentre retrospective study evaluated the 1-year outcomes and safety profile of faricimab in treatment-naïve patients with neovascular age-related macular degeneration (nAMD). Fifty-five patients (57 eyes) underwent loading therapy comprising three monthly faricimab injections. If...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Ryo Mukai, Keiko Kataoka, Koji Tanaka, Yasunori Miyara, Ichiro Maruko, Makiko Nakayama, Yuto Watanabe, Akiko Yamamoto, Yu Wakatsuki, Hajime Onoe, Sorako Wakugawa, Nobuhiro Terao, Taiji Hasegawa, Moeko Kawai, Ruka Maruko, Kanako Itagaki, Jyunichiro Honjo, Annabelle A. Okada, Ryusaburo Mori, Hideki Koizumi, Tomohiro Iida, Tetsuju Sekiryu
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Portfolio 2024-05-01
Serier:	Scientific Reports
Fag:	Faricimab Neovascular age-related macular degeneration Treat-and-extend regimen Visual acuity Retinal morphology Choroidal thickness
Online adgang:	https://doi.org/10.1038/s41598-024-62559-1
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!